Portland, OR -- (SBWIRE) -- 08/22/2017 -- The Global Angiography Devices Market is driven by the advent of advanced products, devices, and technologies in the market and their extensive usage in the treatment of cardiovascular diseases.In addition, rise in the number of cardiovascular diseases is one of the ley drivers of the market. However, poor reimbursement policies and high cost of angiography restrain the market growth. Conversely, unhealthy lifestyle leading to cardiac disease and emergence of novel angiography devices in the market is anticipated to provide lucrative opportunities for the market growth.

Angiography Devices is the process used for medical imaging of blood vessels of the neck, brain, heart, and kidneys. It is performed using contrast agents, such as lohexol and lopamidol, that are injected into the bloodstream through a thin plastic tube (catheter) placed directly in the blood vessel, called angiograms. It is used to detect abnormalities or blockages in blood vessels (called occlusions) throughout the circulatory system, and in some organs to diagnose heart disease, kidney functions, detect kidney cysts or tumors, aneurysm (an abnormal bulge of an artery that can rupture, causing hemorrhage), tumor, blood clot, or arteriovenous malformations (abnormal tangles of veins and arteries) in the brain, and diagnose problems with the retina of the eye. In addition, it is also used to provide an accurate "map" of brain prior to neurosurgery or of the heart prior to open-heart surgery.

The global angiography devices market is segmented on the basis of device, product, procedure, application, indication, end user, and region. Based on device, it is categorized into computed tomography (CT) angiography devices, magnetic resonance angiography (MRA) devices, and X-ray angiography devices. On the basis of product, it is classified into catheter tubes, angiography systems, balloons, guidewires, vascular closure devices, contrast media, and accessories. Based on application, it is bifurcated into diagnostic and therapeutic. On the basis of procedure, it is divided into coronary angiography, micro-angiography, non-coronary angiography, and others.

The non-coronary angiography segment further involves neuro-vascular angiography and peripheral angiography. On the basis of indication, the market is classified into known/suspected coronary artery disease (CAD), congenital heart disease, congestive heart failure, valvular heart disease, and others. Based on end user, it is divided into diagnostic centers, hospitals, and academic research laboratories. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key market players profiled in the report include Toshiba Medical Systems Corporation, St. Jude Medical, Inc., Siemens AG, Shimadzu Corporation, Medtronic Plc, Koninklijke Philips N.V., General Electric Company, Johnson & Johnson Private Limited, Boston Scientific Corporation, Abbott Laboratories, and Cook Medical Inc.

Key Market Benefits

- The study provides an in-depth analysis of the global angiography devices market along with the current trends and future estimations to elucidate the imminent investment pockets.

- It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities

- Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

- Extensive analysis of the market by devices type assists to understand the availability of various forms of devices used in angiography devices.

Early buyers will receive 20% customization on this report

Get PDF Brochure of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/2854